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A 63-year-old man with a history of hepatitis-B-related hepatocellular carcinoma (HCC) in the left lateral portion of the liver 
received repeated transcatheter arterial chemoembolization (TACE) and salvage radiotherapy. Two months after completing 
radiotherapy, he presented with dysphagia, epigastric pain, and a protruding abdominal mass. Computed tomography showed 
that the bulging mass was directly invading the adjacent stomach. Endoscopy revealed a fistula from the HCC invading the 
stomach. Although the size of the mass had decreased with the drainage through the fistula, and his symptoms had gradually 
improved, he died of cancer-related bleeding and hepatic failure. This represents a case in which an HCC invaded the stomach 
and caused a hepatogastric fistula after repeated TACE and salvage radiotherapy. (Korean J Hepatol 2010;16:401-404)
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INTRODUCTION
Hepatocellular carcinoma (HCC) is the most common 
primary liver cancer and is now the fifth most common cancer 
worldwide.
1 In South Korea, HCC is the fourth most common 
cancer and the third most common cause of cancer-related 
death.
2 With recent improvements in diagnostic and treatment 
strategies, survival of patients with HCC had been prolonged 
significantly.
1 Consequently, the incidence of extrahepatic meta-
stases by HCC is increasing, which currently accounts for 
37~64% of all.
1 Of various organs, the lung is the most common 
site for metastasis, followed by regional lymph nodes and bones.
3 
In contrast, metastasis to gastrointestinal (GI) tracts by HCC 
rarely occurs, being found in only 0.7 to 2% of all HCC 
patients.
4-6 Previous case reports proposed that metastasis of 
HCC mainly occurred through direct invasion, hematogenous 
spread, or peritoneal seeding.
3,5,7 Among them, direct invasion of 
HCC was known to be the most common route of metastasis to 
the GI tract.
3,8,9 Although most metastases of HCC to the GI tract 
are incidentally found through imaging study or autopsy because 
of their asymptomatic presentation,
9,10 hemorrhage from the GI 
tract is the most frequent manifestation in case of direct invasion 
to GI tract by HCC.
7,11,12 In this report, we described a case of 
hepatogastric fistula caused by HCC after repeated transarterial 
chemoembolization (TACE) and salvage radiotherapy with a re-
view of the literature.
CASE REPORT
A 63-year-old man visited our institute, complaining of 
dysphagia and postprandial epigastric pain. Physical examina-
tion revealed palpable abdominal mass in the epigastric area and 
laboratory findings were not remarkable except high alkaline 
phosphatase (118 IU/mL) and bilirubin (1.6 mg/dL) levels. Two 
years ago, he was diagnosed as having hepatitis B virus-related 
HCC based on computed tomography (CT) and hepatic angiog-
raphy results demonstrating two hepatic masses compatible with 
HCC (8.0×8.0 cm in segment III and 3.0×2.5 cm sized in 402  The Korean Journal of Hepatology Vol. 16. No. 4, December 2010
Figure 1. Computed tomography showed direct invasion of the 
stomach by the hepatocellular carcinoma.
Figure 2. Upper gastrointestinal endoscopy showed protrusion of 
a tumor into the gastric lumen and opening of a hepatogastric fistula.
Figure 3. The microscopic appearance of the interface between 
the gastric wall and the tumor was indicative of a poorly 
differentiated hepatocellular carcinoma (hematoxylin-eosin stain, 
×100).
Figure 4. Follow-up computed tomography showed the formation
of a fistula (arrows) between the necrotic hepatocellular carcinoma
and stomach.
segment VIII) with elevated serum alpha-fetoprotein concen-
tration of 50,202 IU/mL. Follow-up CT scan after three sessions 
of TACE revealed that HCC in the right lobe was completely 
filled with lipiodol, but HCC in the left lobe still showed viability 
in spite of size reduction. Thereafter, he was found with ruptured 
HCC in the left lobe and underwent additional three sessions of 
TACE. However, HCC in the left lobe did not respond to 
repeated TACE, but grew in size. Moreover, it also revealed 
additional suspicious features indicating direct invasion to the 
adjacent stomach wall on CT scan. Therefore, local salvage 
radiotherapy for HCC in the left lobe was administered using 
tumor dose of 4,500 cGy with a daily fraction of 180 cGy. In this 
visit with dysphagia and postprandial epigastric pain, two 
months after the end of radiotherapy, we noted that bulging HCC 
in the left lobe was still directly invading the adjacent stomach 
(Fig. 1). Upper GI endoscopy showed the opening of fistula to 
HCC which was covered with exudates (Fig. 2). Endoscopic 
biopsy through hepatogastric fistula revealed poorly differ-
entiated HCC (Fig. 3). His symptoms were thought to be caused 
by extrinsic compression of the stomach by bulging HCC in the 
left lobe and we consulted with a surgeon for palliative resection. 
However, the resection could not be performed as the patient had 
poor liver reservoir (indocyanine green retention at 15 minutes 
[ICG 15], 39.1%). Two weeks later when he re-visited our 
institute for follow-up, he did not complain about previous 
symptoms of dysphagia and postprandial epigastric pain. Physical 
examination showed that the palpable abdominal mass consid-
erably decreased, and CT scans also indicated marked reduced 
size of the bulging HCC with necrosis in the left lobe (Fig. 4). 
The patient was managed for three months in a conservative 
manner, and was referred to the emergency room of our institute 
with massive hematemesis. Emergency upper GI endoscopy 
confirmed cancer bleeding into the stomach via fistula. Because 
of incomplete hemostasis with argon plasma coagulation, he 
underwent emergency left gastric arterial embolization with 
successful hemostasis. However, his clinical course was 
unfavorable and finally he died of hepatic failure on the 14
th day 
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DISCUSSION
Invasion of the GI tract by HCC is rare and is associated with 
poor prognosis. Chen et al. reported the first such case which 
occurred in 2% (8 out of 396 patients) during the course of 
disease with the median survival of one month (range, two to 
eight weeks) after the diagnosis.
5 Lin et al. reported that 11 out of 
2,237 patients (0.5%) with HCC showed the GI tract involve-
ment, and none of them survived longer than nine months.
13 
Although the incidence of hepatogastric fistula in patients with 
HCC has not yet been reported in South Korea, prognosis after 
the diagnosis of hepatogastric fistula was grave with survival 
time of four months in our case.
The sites invaded by HCC were mainly the stomach, duode-
num, and colon. Besides two case reports about colonic invasion 
by HCC 
14,15 and one case report on duodenal invasion HCC,
10 
there were a few case reports about gastric invasion by HCC in 
English language literature from Pubmed, limited to the past 30 
years.
7-9,11,16,17 The mode of metastasis was presumed to be hema-
togenous or direct invasion by contiguous neoplasm.
3,5,11,13 
Although most cases were asymptomatic, hemorrhage was 
frequent initial manifestation of direct invasion of HCC to the GI 
tract in previous reports.
7,11,12 However, Yo et al indicated that 
gastric perforation was the initial manifestation of gastric in-
vasion by HCC, not hemorrhage.
16 In our patient, dysphagia and 
postprandial epigastric pain was the first presentation, and the 
symptoms disappeared with a sudden shrinkage of the protruding 
HCC on physical examination and CT scan. It might be attribut-
able to the passage of necrotic materials associated with HCC 
through hepatogastric fistula. In addition to dysphagia and post-
prandial epigastric pain, GI tract hemorrhage also developed as a 
delayed complication four months after the diagnosis of 
hepatogastric fistula.
HCC invasion of the GI tract can be diagnosed based on radio-
logic and histologic proofs. Although endoscopic biopsy is still 
the mainstay method to detect GI tract metastasis in patients with 
HCC,
13 Park et al suggested that hypervascular GI tract lesion 
on arterial-phase imaging similar to HCC could be one of the 
criteria used to document metastatic lesion rather than primary 
tumor of the GI tract.
3 However, it is sometimes difficult to 
differentiate metastatic HCC in the GI tract from synchronous 
stomach cancer. This is particularly true where patients have 
documented HCC but lack available tumor tissue or have poorly 
differentiated tissue seen on endoscopic biopsy.
3,13 In our case, 
hepatogastric fistula was confirmed by radiologic, endoscopic, 
and histologic examination.
Since HCC invasion of the GI tract is rare, the exact predispos-
ing factors have not been known yet. Several factors with possi-
ble association with the development of such invasion have been 
suggested. Several reports suggested that direct invasion of HCC 
to the stomach had a tendency to develop in patients with a 
history of loco-regional treatment such as TACE or intra-arterial 
chemotherapy.
5,14,15 Accordingly, it could be hypothesized that 
the mode of direct invasion might be initiated by the adhesion of 
exophytic HCC after loco-regional treatment. That is, TACE for 
such exophytic HCC might induce an inflammatory reaction in 
the contiguous GI tract, which causes the serosal side of GI tract 
to become adherent to tumor capsule.
5,13 However, Park et al 
reported that seven out of 12 patients with direct invasion of GI 
tracts by HCC had no previous treatment, and assumed that the 
main factors for the direct invasion were growth pattern, tumor 
size, and location rather than a previous history of loco-regional 
treatment.
3 In the current study, the patient was treated with 
repeated TACE and radiotherapy on huge, and exophytic HCC 
located in left lobe and the stomach was firmly attached to 
liver. All these factors might have contributed to direct gastric 
invasion by HCC and resulted in the formation of hepatogastric 
fistula.
Some viewed gastrointestinal fistula as a complication after 
radiofrequency ablation therapy,
10,18,19 few reported about hep-
atogastric fistula formed by direct invasion of HCC to the stom-
ach after repeated TACE and salvage radiotherapy. Recently,  
Wang et al reported a case of delayed spontaneous formation of 
hepatogastric fistula nine years after TACE and radiotherapy 
treatment.
20
Although, as mentioned above, hepatogastric fistula formed 
by HCC invasion is rare, it should be considered in patients with 
huge and protruding HCC adjacent to GI tract. Patients should be 
investigated more carefully with extra attention, especially if 
they are scheduled for repeated TACE or radiotherapy as treat-
ment for HCC closed to the GI tract. That is because complica-
tions such as fistula, hemorrhage, and perforation might develop, 
which could lead to rapid deterioration of liver function, limiting 
the chance of treatment, and eventually shortening the survival. 
HCC invasion of the GI tract is expected to become more com-
mon based on the recent increase in the incidence of HCC and 
more frequent utilization of TACE and radiotherapy to treat 
unresectable HCC.404  The Korean Journal of Hepatology Vol. 16. No. 4, December 2010
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